Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 32

Results For "Greater"

618 News Found

Emmes acquires VaxTRIALS
News | October 07, 2023

Emmes acquires VaxTRIALS

VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth


Hermes Pharma to invest €25 million to bolster manufacturing capabilities
News | September 27, 2023

Hermes Pharma to invest €25 million to bolster manufacturing capabilities

The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing


India to launch National Policy on Research and Development and Innovation in Pharma-MedTech
Policy | September 26, 2023

India to launch National Policy on Research and Development and Innovation in Pharma-MedTech

Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)


AIIMS, New Delhi celebrates 68th Foundation Day
News | September 26, 2023

AIIMS, New Delhi celebrates 68th Foundation Day

India is promoting holistic healthcare with emphasis on preventive care


Indraprastha Apollo Hospitals collaborates with MotoGP Bharat
News | September 25, 2023

Indraprastha Apollo Hospitals collaborates with MotoGP Bharat

The medical center at the Buddh International Circuit will be under the care of the Indraprastha Apollo Hospital team


Lupin acquires five brands from Menarini
News | September 23, 2023

Lupin acquires five brands from Menarini

Lupin has been exclusively marketing these brands in the Indian market since July 2021


Philips extends its mobile C-arm range with Zenition 30
News | September 14, 2023

Philips extends its mobile C-arm range with Zenition 30

Alleviating staff shortages by empowering surgeons with greater personalization and control


Qure.ai teams up with PATH India
Digitisation | September 14, 2023

Qure.ai teams up with PATH India

To implement AI-enabled chest X-ray solution for TB & COVID-19 screening in Maharashtra through Unitaid funding


Roche and Alnylam report positive topline results from Phase 2 study KARDIA-1 of zilebesiran
Clinical Trials | September 11, 2023

Roche and Alnylam report positive topline results from Phase 2 study KARDIA-1 of zilebesiran

Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension